AlisQI
AlisQI is a Quality Management platform built for process and batch manufacturers who want operational control without adding administrative overhead.
Where many QMS platforms were designed around document storage and event tracking, AlisQI was architected as a data-first system. Quality, laboratory, and production data are structured and connected in a single operational backbone. This enables teams to see deviations earlier, understand performance trends in context, and act before issues escalate into waste, rework, or customer complaints.
The platform includes modular capabilities across document control, training, deviations, CAPA, audits, risk management, supplier quality, SPC, and EHS. These capabilities are deployed through focused, ready-to-use Solvers that combine workflows, logic, dashboards, and analytics to address specific operational challenges without unnecessary scope.
Because the system is built on structured, connected data, manufacturers can apply practical AI directly inside their workflows. This includes automated extraction of supplier COA data without predefined templates, conversational access to quality records, intelligent rule generation, and pattern recognition across incidents to strengthen corrective action effectiveness.
Solvers are production-ready from the outset and evolve as products, processes, or sites change. Improvements do not require custom development or large IT programs, allowing organizations to modernize quality step by step.
Manufacturers across chemicals, plastics, packaging, food and beverage, automotive, and industrial sectors use AlisQI to reduce firefighting, increase predictability, strengthen compliance, and turn quality data into operational intelligence.
Learn more
Teradata VantageCloud
Teradata VantageCloud: The Complete Cloud Analytics and AI Platform
VantageCloud is Teradata’s all-in-one cloud analytics and data platform built to help businesses harness the full power of their data. With a scalable design, it unifies data from multiple sources, simplifies complex analytics, and makes deploying AI models straightforward.
VantageCloud supports multi-cloud and hybrid environments, giving organizations the freedom to manage data across AWS, Azure, Google Cloud, or on-premises — without vendor lock-in. Its open architecture integrates seamlessly with modern data tools, ensuring compatibility and flexibility as business needs evolve.
By delivering trusted AI, harmonized data, and enterprise-grade performance, VantageCloud helps companies uncover new insights, reduce complexity, and drive innovation at scale.
Learn more
Genedata Biologics
Genedata Biologics® significantly advances the creation of biotherapeutics such as bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, offering an all-encompassing solution for the sector. Esteemed as a premier platform in its domain, it seamlessly integrates all discovery processes, empowering researchers to focus on true innovation. By employing a cutting-edge system specifically designed to digitize the biotherapeutic discovery journey, research timelines can be notably expedited. This platform streamlines complex R&D activities by aiding in the design, tracking, testing, and evaluation of new biotherapeutic entities. It accommodates a variety of formats, including antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, along with engineered therapeutic cell lines like TCRs and CAR-T cells. As a fully integrated data backbone, Genedata Biologics links all R&D activities, from library design and immunization to selection and panning, molecular biology, screening, protein engineering, expression, purification, and analytics, resulting in thorough evaluations of candidate developability and manufacturability. This comprehensive integration not only enables researchers to make well-informed choices but also fosters a culture of exploration and advancement in biotherapeutic innovation. Ultimately, the synergy of these capabilities positions Genedata Biologics as a vital asset in the competitive landscape of biopharmaceutical development.
Learn more
SILCS
Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.
Learn more